Sumitoma Pharma US
Jeffrey Miller is an accomplished technology executive with extensive experience in leading enterprise technology and infrastructure initiatives. Currently serving as VP, Head of Enterprise Technology & Infosec at Sumitomo Pharma America, Inc. since July 2023, Jeffrey previously held the role of VP, Head of Enterprise Technology at Sumitovant Biopharma, Inc. from July 2021 to July 2023, where responsibilities included oversight of enterprise application platforms and user experience enhancement. Prior to this, Jeffrey was VP, Head of Infrastructure & Real Estate at Roivant Sciences, managing a $25 million budget and global infrastructure, and Head of Infrastructure at General Atlantic, where a cloud-first strategy was successfully implemented. Jeffrey's earlier experience includes serving as Chief Technology Officer at Serengeti Asset Management, focusing on technology resources and investment strategies. Educational qualifications comprise an MBA in Technology Management with a Finance Concentration from SUNY Polytechnic Institute and a BS in MSI/Management from the University at Albany.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.